medigraphic.com
ISSN 1561-2996 (Digital)
ISSN 0864-0289 (Impreso)

2012, Número 2

<< Anterior Siguiente >>

Rev Cubana Hematol Inmunol Hemoter 2012; 28 (2)


Células progenitoras hematopoyéticas de sangre de cordón umbilical

Morera-Barrios LM, Jaime-Fagundo JC, Dorticós- Balea E, Ustáriz-García C, Hernández-Ramírez P

Idioma: Español
Referencias bibliográficas: 51
Paginas: 130-140
Archivo PDF: 54.12 Kb.


RESUMEN

La sangre de cordón umbilical (SCU) es una rica fuente de células progenitoras hematopoyéticas (CPH) para el trasplante. Se describe la historia del uso de la SCU para trasplante hematopoyético y la necesidad del consentimiento informado para su obtención, conservación, almacenamiento y uso con estos fines. Se hace referencia a la seguridad para el receptor en cuanto a selección, requisitos epidemiológicos, obstétricos y analíticos de la muestra, la calidad hematopoyética de la colecta y procesamiento hasta su conservación, así como a las ventajas y desventajas de su uso en el trasplante. Por último, se aborda la importancia de incrementar en los bancos de SCU, el almacenamiento de CPH que tengan representación antigénica compatible con las minorías étnicas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Knudtzon S. In vitro growth of granulocyte colonies from circulating cells in human cord blood. Blood. 1974 Mar;43(3):357-61. PMID: 4811820.

  2. Nakata T, Ogama M. Hematopoietic colony forming cells in umbilical cord blood with extensive capability to generate mono and multipotential hematopoietic progenitors. J Clin Invest. 1982 Dec;70(6):1324-8.

  3. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi`s anemia by means of umbilical-cord-blood from an HLA-identical sibling. N Engl J Med. 1989 Oct;321(17):1174-8. PMID: 2571931.

  4. Martínez-Murillo CI. El banco de células madre hematopoyéticas de cordón umbilical para trasplante. Gac Méd Méx. 2003 Septiembre-Octubre;139 (Supl 3):S93-S95.

  5. Gamba C, Marcos MA, Trevani H, van der J, Marcos CY, Theile G, et al. Banco público de sangre de cordón umbilical: etapa inicial del programa no relacionado en Argentina. Acta Bioquim Clin Latinoamer. 2006 Dic;40(4):491-7. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-29572006000400008&lng=es

  6. Rubinstein P. Cord blood banking for clinical trasplantation. Bone Marrow Transplant. 2009 Nov;44(10):635-42. PMID:19802017.

  7. Gluckman E. History of cord blood trasplantation. Bone Marrow Trasplant. 2009 Nov;44(10):621-6. PMID:19802032.

  8. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell trasplantation:marrow or umbilical cord blood? Blood. 2003 Jun;101(11):4233-44. PMID:12522002.

  9. Gluckman E. Ten Years of cord blood transplantation: from bench to bedside. Br J Haematol. 2009 Oct;147(2):192-9. PMID:19796268.

  10. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation Exp Hematol. 2000 Nov;28(11):1197-205. PMID:11063867.

  11. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood. 1996 Oct;88(7):2794-800. PMID: 8839878.

  12. Fruchtman S. Stem cell trasplantation. Mt Sinai J Med. 2003 May;70(3):166-70. PMID:12764534.

  13. Gluckman E, Devergie A, Thierry D, Esperou-Bourdeau H, Traineau R, Gerrota J, et al. Clinical applications of stem cell transfusion from cord and rationales for cord blood banking. Bone Marrow Transplant. 1992;9(Suppl 1):114-7. PMID:1354518.

  14. Gluckman E, Rocha V, Chastang C. Cord blood banking and trasplant in Europe. Eurocor Vox Sang. 1998;74 Suppl 2:95-101. PMID: 9704430.

  15. Freites CO, Beatty PG. Representation of Hispanics in the National Donor Marrow program. Bone Marrow Transplant. 1996 Mar;17(3):323-7. PMID: 8704681.

  16. Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol 2009 Oct;147(2):246-61. PMID:19796274.

  17. Bojanic I, Golubic CB. Umbilical cord blood as source of stem cell. Acta Med Croatica. 2006 Jun;60 (3):215-25. PMID: 16933834.

  18. Jaime JC, Dorticos E, Pavón V, Cortina L. Trasplante de células progenitoras hematopoyéticas: tipos, fuentes e indicaciones. Rev Cub Hematol Hemoter. 2004 Ago;20(2): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892004000200002&lng=es

  19. Auerbach AD, Lui O, Glosh R, Pollack MS, Douglas GW, Broxmeyer HE. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi. Transfusion. 1990 Oct;30(8):682-7. PMID: 2219253.

  20. Broxmeyer HE, Gordon GW, Hangoc G, Cooper S, Bard J, English D, et al. Human umbilical cord blood as potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA.1989 May;86(10):328-32. PMID: 2566997.

  21. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anemia application to conditioning regimen for bone marrow trasplantation. Br J Haematol. 1983 Jul;54(3):431- 40. PMID: 6344915.

  22. Rocha V, Wagner JE, Sobocinski K, Klein JP, Zhang MJ, Horowitz MM. Graft-versushostdisease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000 Jun;342(25):1846-54. PMID: 10861319.

  23. Rocha V, Cornish J, Siervers E, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes unrelated of bone marrow and cord blood transplants in children with acute leukemia. Blood. 2001 May;97(10):2962-71. PMID: 11342418.

  24. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Trasplants of umbilical cord blood or marrow from unrelated donor in adults with acute leukemia. N Engl J Med. 2004 Nov;351(22):2276-85. PMID:15564544.

  25. Laughlin MJ, Eapen M, Rubinistein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors with leukemia. N Engl J Med. 2004 Nov;351(22):2265-75. PMID:15564543.

  26. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9. PMID:17222756.

  27. Baker JN, Weisdorf DF, Defor TE, Blazar BR, Miller JS, Wagner JE. Rapid an complete donor chimerism in adults recipients of unrelated donor umbilical cord blood transplantation after reduced_intensity conditioning. Blood. 2003 Sep;102(5):1915-19. PMID:12738676.

  28. Rebulla P. Cord blood banking. Transfusion. 2002 Oct;42(10):1246-8. PMID:12423505.

  29. Kusminsky G. Bancos de Sangre de cordón: ¿para qué? ¿Para quién? Hematología. 2004;8(3):65.

  30. Querol S, Rubinstein P, Marsh SG, Goldman J, Madrigal JA. Cord blood banking: proving cord blood banking for a nation. Br J Haematol. 2009 Oct:147(2):227-35. PMID: 19796272.

  31. Samuel GN, Kerridge IH, O'Brien TA. Umbilical cord blood banking: public good or private benefit? Med J Aust. 2008 May;188(9):533-5. PMID:18459926.

  32. Solves Alcalina P, Perales Marin A, Mirabet Lis V, Brik Spinelli M, Soler García MA, Roig Oltra R. Donors selection and retieval of units in an umbilical cord blood bank. Med Clin (Barc). 2007 Oct;129(15):561-5. PMID:17988611.

  33. Solves P, Perales A, Moraga R, Saucedo E, Soler MA, Monleon J. Maternal, neonatal and collection factors influencing the haematopoietic content of cord blood units. Acta Haematol. 2005;113(4):241-6. PMID: 15983430.

  34. Torrico C. II. El proceso del banco de sangre de cordón umbilical. Gac Méd Méx. 2003 Septiembre-Octubre;139(Supl 3):S96-S98.

  35. Lasky LC, Lane TA, Miller JP, Lindgren B, Patterson HA, Haley NR, et al. In utero or exutero cord blood collection:which is better? Transfusion. 2002 Oct;42(10):1261-7. PMID:12423508.

  36. Rocha V, Broxymeyer H. New approaches for improving engraftment after cord blood trasplantation. Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S1 26-32. PMID:19896543.

  37. Jones J, Stevens CE, Rubinstein P, Robertazzi RR, Kerr A, Cabbad MF. Obstetric predictors of placental /umbilical cord blood volume for trasplantation. Am J Obstet Gynecol. 2003 Feb;188(2):503-9. PMID:12592263.

  38. Serrano-Delgado M, Novello-Garza B, Valdez- Martínez E. Ethical issues relating to the banking of umbilical cord blood in Mexico. BMC Med Ethics. 2009 Aug;10:12. doi:10.1186/1472-6939-10-12.

  39. Gunning J. Umbilical cord cell banking implication for the future. Toxicol Appl Pharmacol. 2005 Sep;207(2 Suppl):538-43. PMID:15982697.

  40. Sanz MA. Cord- blood trasplantation in patients with Leukemia. A real alternative for adults. N Engl J Med. 2004 Nov;351(22):2328-30. PMID:15564549.

  41. Samuel GN, Kerridge IH, Volwels M, Trickett A, Chapman J, Dobbins T. Ethicity, equity and public benifit a critical evaluation of public umbilical cord blood banking in Australia. Bone Marrow Trasplant. 2007 Oct;40(8):729-34. PMID:17700599.

  42. Ballen KK, Hicks J, Dharan B, Ambruso D, Andreson K, Bianco C, et al. Racial and ethnics composition of volunteer cord blood donors:comparison with voluteer unrelated marrow donors. Transfusion. 2002 Oct;42(10):1279-84. PMID:12423511.

  43. Buljan Culej J. Cord blood banks. Acta Med Croatica. 2007 Dec;61(5):459-62. PMID:18350806.

  44. Brown J, Poles A, Brown CJ, Contreras M, Navarrete CV. HLA-A,-B, -DR antigen frequencies of the London Cord Blood Banks units differ from those found in established bone marrow donor registries. Bone Marrow Transplant. 2000 Mar;25(5):475-81. PMID:10713622.

  45. Hurley CK, Maiers M, Marsh SG, Oudshoorn M. Overvierw of registries, HLA typing and diversity, and search algoritms.Tissue Antigens. 2007 Apr;69(Suppl 1):3-5 PMID:17445151.

  46. Wofford J, Kemp J, Regan D, Creer M. Ethnically mismatches cord blood trasplants in African Americans: the Saint Louis cord blood bank experince. Cytotherapy. 2007;9 (7):660-6. PMID:17917882.

  47. Ballen KK. New trends in umbilical cord blood transplantation. Blood. 2005 May;105(10):3786-91. PMID:15677563.

  48. Pavón V, Dorticós E, Jame JC, Carnot J. Trasplante no mieloablativo de celulas hematopoyéticas. Rev Cubana Hematol Inmunol Hemoter. 2003 Dic;19(2-3): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892003000200004&lng=es

  49. Cutler CN, Ballen K. Reduced- intensity conditioning and umbilical cord blood transplantation in adults. Bone Marrow Trasplant. 2009 Nov;44(10):667-71. PMID:19802028.

  50. Matsunol N, Wake A, Uchida N, Ishiswata K, Aroaka H, Takagi S, et al. Impact of HLA disparity in graft-versus-host direction on engrafment in adult patients receiving reduced intensity cord blood trasplantation. Blood. 2009 Ago;114 (8):1689-95. PMID:19535797.

  51. Lujungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, et al. Allogenic and autologous trasplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Trasnplant. 2010 Feb;45(2):219-34. PMID:19584824.




2020     |     www.medigraphic.com